Refine
Has Fulltext
- yes (10)
Is part of the Bibliography
- yes (10)
Document Type
- Journal article (9)
- Conference Proceeding (1)
Language
- English (10)
Keywords
- 18F-FDG (2)
- Medizin (2)
- PET (2)
- TKI (2)
- positron emission tomography (2)
- vandetanib (2)
- 2-deoxy-2-(18F)fluoro-D-glucose (1)
- 68Ga-DOTATATE (1)
- American Thyroid Association (1)
- Atherosclerotic plaque (1)
- BRAF(V600E) mutation (1)
- Cardiovascular risk factors (1)
- Combination (1)
- DWI (1)
- EBRT (1)
- Extraocular eye muscles (1)
- Gehirn (1)
- German population (1)
- Insulin (1)
- Macrophage (1)
- Maus (1)
- Meningioma (1)
- Merkel cell carcinoma (1)
- Metastases (1)
- Molecular imaging (1)
- PET/CT (1)
- PRRT (1)
- Peptide receptor radionuclide therapy (1)
- Positron emission tomography (1)
- Positronen-Emissions-Tomografie (1)
- Radiotherapy (1)
- Rhabdomyosarcoma (1)
- Skelettmuskel (1)
- Somatostatin receptor (1)
- Somatostatin receptor expression (1)
- association (1)
- cancer (1)
- differentiated thyroid cancer (1)
- dissection (1)
- distant metastases (1)
- guidelines (1)
- inconsistencies (1)
- management (1)
- medullary thyroid carcinoma (1)
- papillary (1)
- personalized medicine (1)
- radioiodine therapy (1)
- surgery (1)
- tyrosine kinase inhibitor (1)
Institute
- Klinik und Poliklinik für Nuklearmedizin (6)
- Medizinische Klinik und Poliklinik I (3)
- Klinik und Poliklinik für Strahlentherapie (2)
- Institut für diagnostische und interventionelle Neuroradiologie (ehem. Abteilung für Neuroradiologie) (1)
- Institut für diagnostische und interventionelle Radiologie (Institut für Röntgendiagnostik) (1)
- Kinderklinik und Poliklinik (1)
- Klinik und Poliklinik für Dermatologie, Venerologie und Allergologie (1)
- Medizinische Fakultät (1)
- Neurologische Klinik und Poliklinik (1)
- Pathologisches Institut (1)
Sonstige beteiligte Institutionen
EU-Project number / Contract (GA) number
- 701983 (2)
Background: We evaluated the effect of insulin stimulation and dietary changes on myocardial, skeletal muscle and brain [18F]-fluorodeoxyglucose (FDG) kinetics and uptake in vivo in intact mice. Methods: Mice were anesthetized with isoflurane and imaged under different conditions: non-fasted (n = 7; "controls"), non-fasted with insulin (2 IU/kg body weight) injected subcutaneously immediately prior to FDG (n = 6), fasted (n = 5), and fasted with insulin injection (n = 5). A 60-min small-animal PET with serial blood sampling and kinetic modeling was performed. Results: We found comparable FDG standardized uptake values (SUVs) in myocardium in the non-fasted controls and non-fasted-insulin injected group (SUV 45-60 min, 9.58 ± 1.62 vs. 9.98 ± 2.44; p = 0.74), a lower myocardial SUV was noted in the fasted group (3.48 ± 1.73; p < 0.001). In contrast, the FDG uptake rate constant (Ki) for myocardium increased significantly by 47% in non-fasted mice by insulin (13.4 ± 3.9 ml/min/100 g vs. 19.8 ± 3.3 ml/min/100 g; p = 0.030); in fasted mice, a lower myocardial Ki as compared to controls was observed (3.3 ± 1.9 ml/min/100 g; p < 0.001). Skeletal muscle SUVs and Ki values were increased by insulin independent of dietary state, whereas in the brain, those parameters were not influenced by fasting or administration of insulin. Fasting led to a reduction in glucose metabolic rate in the myocardium (19.41 ± 5.39 vs. 3.26 ± 1.97 mg/min/100 g; p < 0.001), the skeletal muscle (1.06 ± 0.34 vs. 0.34 ± 0.08 mg/min/100 g; p = 0.001) but not the brain (3.21 ± 0.53 vs. 2.85 ± 0.25 mg/min/100 g; p = 0.19). Conclusions: Changes in organ SUVs, uptake rate constants and metabolic rates induced by fasting and insulin administration as observed in intact mice by small-animal PET imaging are consistent with those observed in isolated heart/muscle preparations and, more importantly, in vivo studies in larger animals and in humans. When assessing the effect of insulin on the myocardial glucose metabolism of non-fasted mice, it is not sufficient to just calculate the SUV - dynamic imaging with kinetic modeling is necessary.